—————————————————————-
One pen, one injection, once a week. The routine sounds simple, but the decisions around Zepbound dosing are genuinely medical ones, made by a licensed prescriber who knows your health history, your other medications, and how you are tolerating treatment. This guide explains what the FDA label describes about Zepbound dosing and why those figures are a framework your prescriber applies, not a schedule you follow on your own. It is educational only. It is not medical advice, not a self-dosing plan, and not a substitute for the instructions your prescriber and pharmacist give you.
Important: Zepbound (tirzepatide) is a prescription-only medication that must be dosed and adjusted under a prescriber’s supervision. Do not use this article to start, increase, decrease, or change your dose. Only your prescriber can decide what dose is right for you, whether to move up, and whether to hold or step back. Never self-titrate, never split or share pens, and never use compounded or counterfeit tirzepatide. If you think you have taken too much, contact Poison Control at 1-800-222-1222, or call 911 for a medical emergency.
How Zepbound Is Delivered
Zepbound (tirzepatide) is a once-weekly subcutaneous injection. It is supplied in single-dose prefilled pens and single-dose vials, and each is a fixed strength, produced in 2.5, 5, 7.5, 10, 12.5, and 15 mg options. It is injected into the abdomen, thigh, or upper arm. According to the FDA prescribing information, the medication can be taken at any time of day, with or without food, on the same day each week.
Prescribers generally recommend rotating injection sites to reduce skin reactions and tissue changes at any single spot. Your prescriber or pharmacist will show you the correct injection technique; follow their instructions rather than a generic online description.
What the FDA Label Describes About Escalation (Set by Your Prescriber)
The figures below describe how the FDA label structures tirzepatide dosing. They are provided for general understanding. They are not a plan for you to follow, and your prescriber may do something different for good clinical reasons.
The label describes starting at a low dose (2.5 mg once weekly), which is used to begin treatment and is not intended as a maintenance dose. After at least four weeks, the label describes increasing to 5 mg once weekly, with any further increases made in 2.5 mg increments and no sooner than every four weeks. The maximum described dose is 15 mg once weekly. For chronic weight management, maintenance is described at 5, 10, or 15 mg once weekly; for obstructive sleep apnea, the described maintenance doses are 10 or 15 mg once weekly.
The purpose of this gradual, unhurried escalation is to reduce gastrointestinal side effects. Moving up faster than the label describes can increase the risk of severe nausea, vomiting, dehydration, and related problems. Crucially, deciding whether and when to move to the next dose is a clinical judgment your prescriber makes based on your response, not something to time yourself against a calendar. Your prescriber may keep you at a dose longer than four weeks, and that is a normal, deliberate choice, not a failure.
Why You Should Never Self-Titrate
It can be tempting to treat the numbers above as a ladder to climb on your own, but doing so is unsafe. Your prescriber weighs your tolerance, weight trajectory, other medical conditions, and other medications before making any change, and they can hold, slow down, or step your dose back down when that is the safer path. Signs such as ongoing nausea, dehydration, or unusually rapid weight loss are reasons to contact your prescriber, not cues to adjust the dose yourself. If side effects are troubling you, the right move is a call to your prescriber’s office, who may adjust the plan.
Two absolute rules: never split, combine, or “double up” doses, and never share a pen with anyone else, even someone on the same medication. Sharing pens can transmit infection, and doubling doses amplifies side effects without improving results.
Timing, Missed Doses, and Gaps in Therapy
The label allows some flexibility in the day of the week, provided a minimum interval between doses is respected, and your prescriber can tell you how to shift your injection day safely if you need to. Pick a day you can remember consistently.
If you miss a dose, the label describes general rules for whether to take it or skip it depending on how soon your next dose is due, but the safest step is to follow the instructions your prescriber and pharmacist gave you and to contact them if you are unsure. For longer interruptions, whether from supply, insurance, or travel, do not simply resume where you left off; your prescriber may restart you at a lower dose to re-establish tolerance. For cost-related gaps, see our cheapest way to get Zepbound without insurance guide, but bring any gap in therapy to your prescriber before restarting.
Do Not Use Compounded or Counterfeit Tirzepatide
During the 2022-2024 shortage, compounded versions of tirzepatide became widely available. The FDA declared the tirzepatide shortage resolved in 2024, and the enforcement grace period for compounding wound down in 2025; the agency has moved to close the door on mass-compounded GLP-1 medicines and has issued numerous warnings about copycat, compounded, and counterfeit products sold online. These products are not FDA-approved and are not verified for safety, strength, or purity, and counterfeit pens have been found in the supply chain. Use only FDA-approved Zepbound obtained through a legitimate pharmacy with a valid prescription. If you have been using a compounded product, talk with your prescriber about transitioning safely rather than stopping or switching on your own.
Managing Side Effects
Nausea is the most common side effect, and it tends to be most noticeable during dose changes. General comfort measures a prescriber may suggest include eating smaller meals, avoiding greasy or fried foods, staying upright for a while after eating, and sipping fluids through the day. Constipation is also common and often responds to fiber, hydration, and gentle movement.
Some symptoms warrant prompt medical attention rather than home management: an inability to keep fluids down, signs of dehydration, severe or persistent abdominal pain (which can signal pancreatitis or gallbladder problems), or symptoms of a severe allergic reaction. Contact your prescriber or seek urgent care for these. Related reading: tirzepatide side effects. For a suspected overdose or a serious dosing error, call Poison Control at 1-800-222-1222 or 911.
Frequently Asked Questions
Can I increase my Zepbound dose on my own if it stops working?
No. Any dose change must be made by your prescriber. A short plateau is common and is not by itself a reason to move up. If your progress has stalled or side effects are limiting you, contact your prescriber’s office so they can decide whether and how to adjust your plan.
Can Zepbound be injected more than once a week?
No. The FDA label specifies once-weekly dosing. More frequent injections increase side effects without better results because tirzepatide has a long half-life that maintains steady levels with weekly dosing.
Do I need to refrigerate Zepbound?
Storage instructions are on your product’s label and patient information leaflet, and generally call for refrigeration with a limited period allowed at room temperature. Never freeze it. Follow the storage directions that came with your specific product and ask your pharmacist if you are unsure.
Is Zepbound the same as Mounjaro?
Both are tirzepatide from Eli Lilly. The dose strengths are the same, but the FDA-approved indications differ: Zepbound is approved for chronic weight management and for obstructive sleep apnea in adults with obesity, while Mounjaro is approved for type 2 diabetes. See our Mounjaro savings card guide for cost context. Which product is appropriate for you is a decision for your prescriber.
What should I take to my next appointment?
A simple log of your injection dates, the dose used, and any side effects gives your prescriber the information they need to make good decisions. See our full Zepbound doses guide and the medical conditions pillar for additional background.
The Bottom Line
Good Zepbound dosing is a partnership in which your prescriber sets and adjusts the plan and you report honestly how you are doing. The label’s numbers describe a careful, gradual approach, but they are a framework for your clinician to apply, not a schedule to run yourself. Do not self-titrate, do not use compounded or counterfeit tirzepatide, and bring every dosing question to your prescriber or pharmacist.
Sources
- FDA Prescribing Information, ZEPBOUND (tirzepatide) – accessdata.fda.gov
- Zepbound (Lilly), HCP Dosage information – zepbound.lilly.com
- Drugs.com, Zepbound Dosage Guide – drugs.com
- Pharmacy Times, FDA moves to close the door on compounded GLP-1s – pharmacytimes.com
- Poison Control (Poison Help), 1-800-222-1222 – poison.org